| Not Yet Recruiting | The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy NCT07475065 | Universitas Sebelas Maret | Phase 2 / Phase 3 |
| Recruiting | Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave NCT06890208 | Universitätsklinikum Hamburg-Eppendorf | — |
| Active Not Recruiting | Progressive Advancements in Neurosurgery, Data and Analysis Database NCT06835634 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | A Phase 3 Study of NTLA-2001 in ATTRv-PN NCT06672237 | Intellia Therapeutics | Phase 3 |
| Completed | Chronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, NCT06407154 | Universitätsklinikum Hamburg-Eppendorf | — |
| Terminated | Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study NCT05961163 | Universitätsklinikum Hamburg-Eppendorf | — |
| Recruiting | MUSic Therapy In Complex Specialist Neurorehabilitation NCT05777499 | University College, London | N/A |
| Completed | Evaluate the Safety and Pharmacokinetics of Ricolinostat NCT05193851 | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | Phase 1 |
| Completed | A Study to Investigate the Safety and Efficacy of Ricolinostat NCT05229042 | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | Phase 1 |
| Completed | Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN NCT05133947 | Beijing 3E-Regenacy Pharmaceuticals Co., Ltd. | — |
| Unknown | Dextrose, Corticosteroids and Surgical Release in Carpal Tunnel Syndrome NCT04014244 | University Medical Centre Ljubljana | N/A |
| Recruiting | The Effects of AFO Heel Height and Stiffness on Gait NCT04800484 | University of Iowa | N/A |
| Completed | Technique to Measure Type C Fibre Nerve Conduction Velocitynerve Fibers in Polyneuropathies NCT03870295 | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | N/A |
| Completed | StimRouter Registry Clinical Protocol NCT03913689 | Bioness Inc | — |
| Completed | Treatment for Ulnar Neuropathy at the Elbow NCT03651609 | University Medical Centre Ljubljana | N/A |
| Not Yet Recruiting | Walking Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project NCT03556709 | Baltimore VA Medical Center | N/A |
| Not Yet Recruiting | Seated Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project NCT03530592 | Baltimore VA Medical Center | N/A |
| Withdrawn | Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy NCT02492360 | Costantine Albany | — |
| Withdrawn | Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People Wi NCT03109301 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Chronic Neuropathy Following Chemotherapy NCT02654691 | Danish Pain Research Center | — |
| Unknown | Peripheral Physiological Measures as Determinants of Pain Risk NCT02985294 | Neuroscience Technologies SLP, Barcelona | — |
| Completed | Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy NCT02760654 | University of Michigan | N/A |
| Completed | A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects W NCT02552277 | Celularity Incorporated | Phase 2 |
| Completed | The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain NCT01954199 | Federal University of Health Science of Porto Alegre | N/A |
| Completed | Effect of Physical Therapy in Improving the Health of Patients With Diabetic Peripheral Neuropathy NCT02115932 | National University Health System, Singapore | N/A |
| Unknown | Effectiveness of Controlled-perturbation Gait Training on Gait Rehabilitation and Fear of Falling in Individua NCT02031757 | Hadassah Medical Organization | N/A |
| Completed | Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study NCT01465620 | Henri Mondor University Hospital | Phase 3 |
| Terminated | Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy NCT00832572 | Gilead Sciences | Phase 4 |
| Completed | Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy NCT00321672 | NeurogesX | Phase 3 |
| Completed | Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NCT00300222 | NeurogesX | Phase 3 |
| Completed | Effect of Exercise on Gait and Balance in Peripheral Neuropathy NCT00270842 | US Department of Veterans Affairs | N/A |
| Completed | Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (P NCT00233155 | NeurogesX | Phase 2 |
| Completed | Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NCT00115310 | NeurogesX | Phase 3 |
| Completed | Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy NCT00064623 | NeurogesX | Phase 3 |
| Completed | Marijuana for HIV-Related Peripheral Neuropathy NCT00046722 | Center for Medicinal Cannabis Research | Phase 1 / Phase 2 |
| Completed | Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain NCT00034710 | NeurogesX | Phase 2 |
| Completed | Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy NCT00041795 | NeoTherapeutics | Phase 2 |
| Completed | NGX-4010 for the Treatment of Postherpetic Neuralgia NCT00061776 | NeurogesX | Phase 2 / Phase 3 |
| Completed | Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy NCT00050271 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Terminated | An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain NCT00089557 | NeurogesX | Phase 2 |
| Terminated | Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy NCT00085761 | NeurogesX | Phase 3 |
| Completed | Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NCT00068081 | NeurogesX | Phase 3 |
| Completed | Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropat NCT00082316 | NeurogesX | Phase 2 |